MDxHealth SA (OTCMKTS:MXDHF – Get Free Report) fell 9.1% during mid-day trading on Monday . The stock traded as low as $0.25 and last traded at $0.25. 300 shares traded hands during trading, a decline of 70% from the average session volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Stock Performance
The company has a quick ratio of 1.19, a current ratio of 1.25 and a debt-to-equity ratio of 1.45. The stock has a fifty day moving average price of $0.25.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Featured Stories
- Five stocks we like better than MDxHealth
- Most Volatile Stocks, What Investors Need to Know
- Intel: Is Now the Time to Be Brave?
- Profitably Trade Stocks at 52-Week Highs
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Retail Stocks Investing, Explained
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.
